NCT07415031 2026-02-17
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
Phase 2 Not yet recruiting
Mirati Therapeutics Inc.
Intergroupe Francophone de Cancerologie Thoracique
Convalife (Shanghai) Co., Ltd.
Shandong Cancer Hospital and Institute